pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4763 |
Genomic Coordinates | chr22: 46113566 - 46113657 |
Description | Homo sapiens miR-4763 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4763-5p | |||||||||||||||||||||||||||||||||
Sequence | 19| CGCCUGCCCAGCCCUCCUGCU |39 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NBPF11 | ||||||||||||||||||||
Synonyms | NBPF24 | ||||||||||||||||||||
Description | NBPF member 11 | ||||||||||||||||||||
Transcript | NM_183372 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NBPF11 | |||||||||||||||||||||
3'UTR of NBPF11 (miRNA target sites are highlighted) |
>NBPF11|NM_183372|3'UTR 1 TGGAAGTGGAAGTGCCTGAAGTCTTACAGGACTCACTGGATAGATATTATTCGACTCCATCAATGTACTTTGAACTACCT 81 GACTCATTCCAGCACTACAGAAGTGTGTTTTACTCATTTGAGGAACAGCACATCAGCTTTGCCCTTGACATGGACAATAG 161 GTTTTTTACTTTGACGGTGAGAAGTCTCCACCTGGTCTTCCAGATGGGAGTCATATTCCCACAATAAGCAGCCCTTACTA 241 AGCCGAGAGGTGTCATTCCTGCAGGCAGGACCTATAGGCACCTGAAGATTTGAATGAAACTATAGTTCCATTTGGAAGCC 321 CAGACATAGGATGGGTCAGTGGGCATGGCTCTATTCCTATTCTCAGAGCATGCCAGTGGCAACCTGTGCTCAGTCTGAAG 401 ACAATGGACCCACGTTAGGTGTGACACGTTCACATAACTGTGCAGCACATGCCGGGAGTGATCAGTCGGACATTTTAATT 481 TGAACCACGTATCTCTGGGTAGCTACAAAATTCCTCAGGGATTTCATTTTGCAGGCATGTCTCTGAGCTTCTATACCTGC 561 TCAAGGTCAGTGTCATCTTTGTGTTTAGCTCATCCAAAGGTGTTACCCTGGTTTCAATGAACCTAACCTCATTCTTTGTG 641 TCTTCAGTGTTGGCTTGTTTTAGCTGATCCATCTGTAACACAGGAGGGATCCTTGGCTGAGGATTGTATTTCAGAACCAC 721 CAACTGCTCTTGACAATTGTTAACCCGCTAGGCTCCTTTGGTTAGAGAAGCCACAGTCCTTCAGCCTCCAATTGGTGTCA 801 GTACTTAGGAAGACCACAGCTAGATGGACAAACAGCATTGGGAGGCCTTAGCCCTGCTCCTCTCAATTCCATCCTGTAGA 881 GAACAGGAGTCAGGAGCCGCTGGCAGGAGACAGCATGTCACCCAGGACTCTGCCGGTGCAGAATATGAGCAATGCCATGT 961 TCTTGCAGAAAACGCTTAGCCTGAGTTTCATAGGAGGTAATCACCAGACAACTGCAGAATGTAGAACACTGAGCAGGACA 1041 ACTGACCTGTCTCCTTCACATAGTCCATATCACCACAAATCACACAACAAAAAGGAGAAGAGATATTTTGGGTTGAAAAA 1121 AAGTAAAAAGATAATGTAGCTGCATTTCTTTAGTTATTTTGAACCCCAAATATTTCCTCATCTTTTTGTTGTTGTCATGG 1201 ATGGTGGTGACATGGACTTGTTTATAGAGGACAGGTCAGCTGTCTGGCTCAATGATCTACATTCTGAAGTTGTCTGAAAA 1281 TGTCTTCATAATTAAATTCAGCCTAAACTTTTTGACGGGAACACTGCAGAGACAATGCTGTGAGTTTCCAACCTCAGCCC 1361 ATCTGCGGGCAGAGAAGGTCTAGTTTGTCCAACACCATTATGATATCAGGACTGGTTACTTGGTTAAGGAGGGGTCTAGG 1441 AGATCTGTCCCTTTTAGAGACACCTTACTTATAATGAAGTACTTGGGAAAGTGGTTTTCAAGAGTATAAATATCCTGTAT 1521 TCTAATGATCATCCTCTAAACATTTTATCATTTATTAATCCTCCCTGCCTGTGTCTATTATTATATTCATATCTCTACGC 1601 TGCAAATTTTGGGTCTCAATTTTTACTGTGCCTTTGTTTTTACTAGTGTCTGCTGTTGCAAAAAGAAGAAAACATTCTTT 1681 GCCTGAGTTTTAATTTTTGTCCAAAGTTAATTTTAATCTATACAATTAAAACCTTTTGCCTATCACTCTGGACTTTTGGA 1761 TTGTTTTTTACATTCAGTGTTATAATATTTGATTATGCTGATTGGTTTTGGTGGGTACTGATGCGAATTAATAAAAACAT 1841 TTCATTTCCAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_183372 | 3UTR | GAACCACGUAUCUCUGGGUAGCUACAAAAUUCCUCAGGGAUUUCAUUUUGCAGGCAUGUCUCUGAGCUUCUAUACCUGCUCAAGGUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_183372 | 3UTR | UGAACCACGUAUCUCUGGGUAGCUACAAAAUUCCUCAGGGAUUUCAUUUUGCAGGCAUGUCUCUGAGCUUCUAUACCUGCUCAAGGUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_183372 | 3UTR | UUUGAACCACGUAUCUCUGGGUAGCUACAAAAUUCCUCAGGGAUUUCAUUUUGCAGGCAUGUCUCUGAGCUUCUAUACCUGCUCAAGGUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_183372 | 3UTR | UUGAACCACGUAUCUCUGGGUAGCUACAAAAUUCCUCAGGGAUUUCAUUUUGCAGGCAUGUCUCUGAGCUUCUAUACCUGCUCAAGGUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_183372 | 3UTR | AUUUGAACCACGUAUCUCUGGGUAGCUACAAAAUUCCUCAGGGAUUUCAUUUUGCAGGCAUGUCUCUGAGCUUCUAUACCUGCUCAAGGUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_183372 | 3UTR | UUAAUUUGAACCACGUAUCUCUGGGUAGCUACAAAAUUCCUCAGGGAUUUCAUUUUGCAGGCAUGUCUCUGAGCUUCUAUACCUGCUCAAGGUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000369226.3 | 3UTR | CUACAAAAUUCCUCAGGGAUUUCAUUUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
69 hsa-miR-4763-5p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT116035 | DEPDC1 | DEP domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT347197 | SIN3B | SIN3 transcription regulator family member B | ![]() |
![]() |
2 | 2 | ||||||
MIRT443248 | C9orf170 | chromosome 9 open reading frame 170 | ![]() |
![]() |
2 | 2 | ||||||
MIRT475164 | IP6K1 | inositol hexakisphosphate kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT495486 | VTI1B | vesicle transport through interaction with t-SNAREs 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT496755 | TGIF2 | TGFB induced factor homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT496863 | C21orf2 | chromosome 21 open reading frame 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499264 | NBPF11 | NBPF member 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499517 | MAFK | MAF bZIP transcription factor K | ![]() |
![]() |
2 | 2 | ||||||
MIRT512952 | MKI67 | marker of proliferation Ki-67 | ![]() |
![]() |
2 | 2 | ||||||
MIRT514656 | NUP93 | nucleoporin 93 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517986 | SLC16A13 | solute carrier family 16 member 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT522816 | KLHL9 | kelch like family member 9 | ![]() |
![]() |
2 | 4 | ||||||
MIRT525495 | CD63 | CD63 molecule | ![]() |
![]() |
2 | 2 | ||||||
MIRT528111 | FOXH1 | forkhead box H1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531683 | MYO3A | myosin IIIA | ![]() |
![]() |
2 | 2 | ||||||
MIRT534806 | RAB37 | RAB37, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT573041 | SHMT1 | serine hydroxymethyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT576720 | Wars | tryptophanyl-tRNA synthetase | ![]() |
![]() |
2 | 2 | ||||||
MIRT609727 | MLXIPL | MLX interacting protein like | ![]() |
![]() |
2 | 2 | ||||||
MIRT610843 | FAM180B | family with sequence similarity 180 member B | ![]() |
![]() |
2 | 4 | ||||||
MIRT614735 | STAT5A | signal transducer and activator of transcription 5A | ![]() |
![]() |
2 | 2 | ||||||
MIRT616981 | EPOR | erythropoietin receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT617265 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | ![]() |
![]() |
2 | 2 | ||||||
MIRT619405 | INTS7 | integrator complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621832 | TIMM8A | translocase of inner mitochondrial membrane 8A | ![]() |
![]() |
2 | 2 | ||||||
MIRT621893 | TAF13 | TATA-box binding protein associated factor 13 | ![]() |
![]() |
2 | 2 | ||||||
MIRT630263 | SMIM14 | small integral membrane protein 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634879 | SENP8 | SUMO/sentrin peptidase family member, NEDD8 specific | ![]() |
![]() |
2 | 2 | ||||||
MIRT636863 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | ![]() |
![]() |
2 | 2 | ||||||
MIRT637653 | ADAT1 | adenosine deaminase, tRNA specific 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637699 | ZNF439 | zinc finger protein 439 | ![]() |
![]() |
2 | 2 | ||||||
MIRT637759 | GATAD1 | GATA zinc finger domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638193 | TAOK1 | TAO kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT638996 | ADO | 2-aminoethanethiol dioxygenase | ![]() |
![]() |
2 | 2 | ||||||
MIRT642221 | RABAC1 | Rab acceptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT643327 | ATCAY | ATCAY, caytaxin | ![]() |
![]() |
2 | 4 | ||||||
MIRT643419 | ERVMER34-1 | endogenous retrovirus group MER34 member 1, envelope | ![]() |
![]() |
2 | 2 | ||||||
MIRT644499 | RNF14 | ring finger protein 14 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644603 | NT5DC3 | 5'-nucleotidase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT644795 | C21orf59 | chromosome 21 open reading frame 59 | ![]() |
![]() |
2 | 2 | ||||||
MIRT648732 | HIST1H2BD | histone cluster 1 H2B family member d | ![]() |
![]() |
2 | 2 | ||||||
MIRT653856 | SHE | Src homology 2 domain containing E | ![]() |
![]() |
2 | 2 | ||||||
MIRT654129 | RPL14 | ribosomal protein L14 | ![]() |
![]() |
2 | 4 | ||||||
MIRT658876 | DSN1 | DSN1 homolog, MIS12 kinetochore complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT671624 | C20orf144 | chromosome 20 open reading frame 144 | ![]() |
![]() |
2 | 4 | ||||||
MIRT677367 | HSPA4L | heat shock protein family A (Hsp70) member 4 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT677579 | TRIM65 | tripartite motif containing 65 | ![]() |
![]() |
2 | 2 | ||||||
MIRT678220 | MACC1 | MACC1, MET transcriptional regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT679613 | RRP36 | ribosomal RNA processing 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686081 | PNPLA3 | patatin like phospholipase domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT691817 | ICA1L | islet cell autoantigen 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT693869 | COX19 | COX19, cytochrome c oxidase assembly factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT694544 | BPNT1 | 3'(2'), 5'-bisphosphate nucleotidase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694926 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | ![]() |
![]() |
2 | 2 | ||||||
MIRT697758 | USP37 | ubiquitin specific peptidase 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697891 | UBE2B | ubiquitin conjugating enzyme E2 B | ![]() |
![]() |
2 | 2 | ||||||
MIRT701569 | MYPN | myopalladin | ![]() |
![]() |
2 | 2 | ||||||
MIRT703081 | GPRIN3 | GPRIN family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708104 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT708320 | NT5C | 5', 3'-nucleotidase, cytosolic | ![]() |
![]() |
2 | 2 | ||||||
MIRT709878 | TRAF1 | TNF receptor associated factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713545 | GJB1 | gap junction protein beta 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716275 | NUP85 | nucleoporin 85 | ![]() |
![]() |
2 | 2 | ||||||
MIRT716621 | CRCP | CGRP receptor component | ![]() |
![]() |
2 | 2 | ||||||
MIRT717987 | C9orf171 | cilia and flagella associated protein 77 | ![]() |
![]() |
2 | 2 | ||||||
MIRT718438 | RAB11B | RAB11B, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT722544 | AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT724013 | F2RL1 | F2R like trypsin receptor 1 | ![]() |
![]() |
2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|